|
|
|
| Observation of the Effect of Laparoscopic Sacrocolpopexy on Moderate and Severe Uterine Prolapse |
| TANG Yazhen, XU Xiaozhen, WANG Ronglong, SHI Feifeng |
| Zhangzhou Municipal Hospital, Fujian Province, Zhangzhou 363000, China |
|
|
|
|
Abstract Objective: To investigate the effect of laparoscopic sacrocolpopexy in the treatment of moderate and severe uterine prolapse. Method: A total of 179 patients with moderate and severe uterine prolapse who were admitted to Zhangzhou Municipal Hospital from September 2019 to February 2022 were selected as the research objects, according to different surgical methods, they were divided into experimental group 103 cases (laparoscopic sacrocolpopexy) and control group 76 cases (laparoscopic sacral ligament shortening). The perioperative indexes, the severity of uterine prolapse, quality of life, sexual life and the changes of urinary fluidity were observed in the two groups. Result: The operative time, postoperative catheter indwelling time and postoperative hospital stay of the experimental group were shorter than those of the control group, and the intraoperative blood loss was less than that of the control group, the differences were statistically significant (P<0.05). After treatment, the total effective rate of experimental group was 94.17%, higher than 82.89% of control group (P<0.05). The quality of life scores of experimental group were lower than those of control group at 3 and 6 months after treatment (P<0.05). At 3 and 6 months after treatment, the sexual status scores of experimental group were higher than those of control group (P<0.05). After treatment, the maximum urine flow rate, average urine flow rate and maximum bladder volume in experimental group were higher than those in control group, while the residual urine volume was lower than that in control group, the differences were statistically significant (P<0.05). Conclusion: Laparoscopic sacrocolpopexy can reduce intraoperative blood loss in patients with moderate and severe uterine prolapse, shorten postoperative recovery time, improve the severity of uterine prolapse, improve their quality of life and sexual life, and improve urinary fluidity, which is worthy of clinical promotion.
|
|
Received: 17 January 2023
|
|
|
|
|
|
|
